ACHP Spring 2021 Virtual Clinical Conference High-Value and Equitable Care for Unique Populations
ACHP is hosting its Clinical Collaborative Meeting virtually through Zoo on Wednesday, April 28, 2021 from 11:00am to 4:30pm EST. Keynote Speaker, Rachel Sachs, JD, will be presenting “A Possible Pill for Rising Drug Prices: Medicare Part D Redesign.” This session will cover the various options and proposals regarding redesigning Medicare Part D, implications for ACHP member plans and how Part D redesign fits within the larger drug pricing conversation. Attendees will have time to ask questions of the speaker, a scholar of innovation policy who has written extensively on the topic in Health Affairs. ACHP Member Plan panels will discuss “What’s Needed to Raise the Bar on Maternal Health?” in which attendees will hear about innovative payment and delivery models. Examples that have emerged during ACHP's RWJF work and will be highlighted during this session include initiatives to address mental health conditions, care programs for high-risk mothers and bundled payment. “ACHP Members in Alliance with Rural Communities to Address Chronic Disease Risk” with ACHP plan members from SelectHealth, Pacifica, and Michael Fallahkhair from HRSA, will highlight the evidence base for and methods of co-design; methods of selecting and engaging community partners; and key steps for implementing co-development methods. Content will be targeted at the rural context but will provide applicable advice and tangible takeaways for all participants.
Following this, we will concurrently offer “Gray Hair and Exceptional Care: Advancing Support of Seniors with Complex Needs,” with Cheryl Phillips of SNP Alliance and “A Possible Pill for Rising Drug Prices: Medicare Part D Redesign,” with Rachel Sachs, Washington University School of Law. The former will explore innovative models for older adults with complex care needs. A brief overview of the shift from traditional institutional care to Home and Community-Based Services will lay the foundation for an exploration of models including the PACE program and various SNPs including C-SNPs, IE-SNPs and D-SNPs. Attention will be paid to the growing crisis of elderly homelessness and the potential role of health plans to address it. The session will conclude with a look towards the future, both limiting factors and opportunities to transform care. The second, concurrent session will cover the various options and proposals of redesigning the Medicare Part D benefit, implications for ACHP member plans and the feasibility of passage and implementation. Attendees will have time to ask questions of the speaker, a scholar of innovation policy who has written extensively on the topic in Health Affairs. Our final session, “Saving Kidney Function: Early Detection to Management of End-Stage Renal Disease,” will feature panelists from KP, Geisinger, and Scott & White Health Plans. Panelists will share experiences with innovative chronic kidney disease (CKD) and end-stage renal disease (ESRD) vendor partnerships as well as in-house programs, including data analytics for early detection and the expansion of peritoneal dialysis options.
Participants include ACHP Behavioral Health Directors, Pharmacy Directors, Quality Leaders, Medical Directors and Clinical Executives from ACHP member plans.
At the conclusion of the meeting, Pharmacy Directors, Behavioral Health Leaders, Medical Directors, and Clinical Executives will be able to:
• Better understand and address the care needs of specific populations
• Analyze payment models that support high-value care
• Identify considerations required for addressing inequities
• Share with their respective organization’s innovative payment and delivery models for improved maternal health outcomes
• Identify and apply co-development strategies for addressing chronic disease risk
• Better understand care models for older adults with complex care needs
• Assess/analyze proposals to address rising drug prices through Medicare Part D redesign
• Share with their respective organizations strategies to better prevent, detect and manage CKD and ESRD
Bruce Cantor, MD, MS
UCare Health Plan
Erin Mackay, MPH
Managing Director, Health Justice
National Partnership for Women & Families
Alexander Chang, MD, MS
Assistant Professor Clinical Research
Geisinger Health Plan
Debra Moser PhD, RN, FAHA, FAAN
Assistant Dean of PhD Program & Scholarly Affairs
College of Nursing, University of Kentucky
Amy Christensen, RN
Vice President of Clinical Services
UCare Health Plan
Cheryl Phillips, MD, AGSF
President and CEO
Special Needs Plan Alliance
Michael Fallahkhair, MPH
Principal Advisor at Health Resources and Services Administration (HRSAgov)
Department of Health and Human Services
Leonid Pravoverov, MD, FASN
Medical Director of End Stage Renal Disease
Kaiser Permanente Northern California
Jennifer J. Garber, MSW
Associate VP of Mental Health and Substance Use Disorders
UCare Health Plan
S. (Ram) Ramalingam, MD, MBA
Chief Medical Officer
Scott & White Health Plan
Kimberly Ketchel, MSN, RN, RNC-MNN
Director of Clinical Programs, Maternity and Pediatric Care Management
UPMC Health Plan
Rachel Sachs, J.D.
Associate Professor of Law
St. Louis, MO
Jane Sarasohn-Kahn, MA, MHSA
Advisor, W2O Group
Susan Alger, MSW, LCSW
Director, Care Management
PacificSource Health Plan
Sheila Wilson MBA, BSN, RN, CCM
Director of Care Management: Medicaid, Individual and D-SNP Products
Grand Rapids, MI
Teresa Hall, MBA, BS
Director of Health Services
Park City, UT
Elizabeth Hindbjorgen, RN
Sanford Health Cooperative
Sioux Falls, WI
All individuals in a position to control the content of this education activity are required to disclose all relevant financial relationships with any proprietary entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.
The following relevant financial relationships were disclosed:
• Alex Chang, MD, Novo Norodisk, Grant/Research Support and Reylpsa, Consultant
• Rachel Sachs, JD, MPH, Arnold Ventures, Grant/Research Support, and Institute for Clinical and Economic Review, Consultant Advisory/Review Committee and West Health, Consultant Advisory/Review Committee
• Connie Hwang, MD, Appointed to PCORI Board of Governors (Sept 2020)
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and the Alliance of Community Health Plans. The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 4.0 contact hours.
This knowledge-based activity provides 4.0 contact hours of continuing pharmacy education credit.
Other Healthcare Professionals
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
- 4.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
- 4.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 4.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 4.00 Attendance